|
Index of reports
> Cases with Cytomegalovirus Infection (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cellcept (Mycophenolate Mofetil) where reactions include cytomegalovirus infection. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cellcept side effects in
Reported by a physician from United States on 2012-07-20
Patient:
Reactions: Transplant Failure, Graft Versus Host Disease, Pseudomonas Infection, Mantle Cell Lymphoma, Herpes Zoster, Respiratory Syncytial Virus Infection, Chronic Lymphocytic Leukaemia Recurrent, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytomegalovirus Infection, Sinusitis Fungal, Neutropenia, Influenza
Drug(s) suspected as cause:
Cyclosporine
Dosage: on day 3 taper by 6 months
Indication: Prophylaxis Against Graft Versus Host Disease
Cellcept
Dosage: from day 0 to day 28 for related donors and day 100 for unrelated donors
Indication: Prophylaxis Against Graft Versus Host Disease
Mabthera
Dosage: on day 56, 63, 70, 77 post transplant: infusion: other indication chronic lymphocytic leukemia
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Anti-Thymocyte Globulin NOS
Possible Cellcept side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16
Patient:
Reactions: Neuropathy Peripheral, Viral Infection, Fungal Infection, Cytomegalovirus Infection, Bacterial Infection, Leukopenia
Drug(s) suspected as cause:
Tacrolimus
Dosage: first 3 months 14 ng/ml
Indication: Immunosuppression
Prednisone
Dosage: by 2 years post transplant
Tacrolimus
Dosage: thereafter adjusted to 8-12 ng/ml
Prednisone
Indication: Immunosuppression
Valcyte
Administration route: Oral
Indication: Antiviral Prophylaxis
Cellcept
Administration route: Oral
Indication: Immunosuppression
Basiliximab
Indication: Immunosuppression
Possible Cellcept side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-09
Patient: male, weighing 64.0 kg (140.8 pounds)
Reactions: Hepatitis B Antibody Positive, Epstein-Barr Virus Infection, Post Transplant Lymphoproliferative Disorder, Primary Mediastinal Large B-Cell Lymphoma, Cytomegalovirus Test Positive, Blood Uric Acid Increased, Cytomegalovirus Infection, Pyrexia, Hepatic Neoplasm
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Simulect
Dosage: 20 mg, once/single
Start date: 2007-05-20
End date: 2007-05-20
Cellcept
Dosage: 1500 mg/day
Administration route: Oral
Indication: Renal Transplant
Start date: 2007-05-17
Neoral
Dosage: 500 mg/day
Administration route: Oral
Indication: Renal Transplant
Start date: 2007-05-13
End date: 2007-05-23
Simulect
Dosage: 20 mg, once/single
Indication: Renal Transplant
Start date: 2007-05-16
End date: 2007-05-16
Other drugs received by patient: Sandimmune; Cinalong; Diovan; Solu-Medrol; Zyloric ^fresenius^; Prednisolone; Prednisolone; Allopurinol
Possible Cellcept side effects in male
Reported by a physician from France on 2012-07-05
Patient: male, weighing 63.0 kg (138.6 pounds)
Reactions: Renal Failure, Cytomegalovirus Infection, General Physical Health Deterioration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cellcept
Indication: Transplant Rejection
Start date: 2011-01-29
End date: 2012-01-19
Cyclosporine
Indication: Transplant Rejection
Start date: 2011-01-30
Possible Cellcept side effects in
Reported by a health professional (non-physician/pharmacist) from Ireland on 2012-06-20
Patient:
Reactions: Sepsis, Cytomegalovirus Infection, Human Polyomavirus Infection, Graft Loss
Adverse event resulted in: death
Drug(s) suspected as cause:
Tacrolimus
Prednisolone
Dosage: for 2 days
Prednisolone
Administration route: Oral
Prednisolone
Indication: Prophylaxis Against Transplant Rejection
Azathioprine
Indication: Prophylaxis Against Transplant Rejection
Azathioprine
Administration route: Oral
Prednisolone
Administration route: Oral
Tacrolimus
Indication: Prophylaxis Against Transplant Rejection
Prednisolone
Dosage: for 2 days
Cellcept
Indication: Prophylaxis Against Transplant Rejection
Other drugs received by patient: Valtrex
Possible Cellcept side effects in female
Reported by a physician from Spain on 2012-06-15
Patient: female, weighing 63.5 kg (139.7 pounds)
Reactions: Urinary Tract Infection Enterococcal, Urinary Tract Infection, Cytomegalovirus Infection, Pyrexia, Lung Infiltration
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cellcept
Dosage: current dose: 2000 mg
Cellcept
Dosage: previous dose was 3000 mg
Indication: Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
Cellcept
Cellcept
Cellcept
Other drugs received by patient: Prednisone TAB; Prednisone TAB; Pravastatin; Amlodipine Besylate; Lorazepam; Prednisone TAB; Nitroglycerin; Omeprazole; Clopidogrel; Bisoprolol Fumarate; Enalapril; Aspirin; Azathioprine; Citalopram Hydrobromide; Prednisone TAB; Azathioprine; Enoxaparin; Alendronate Sodium; Cotrim; Prednisone TAB; Furosemide; Calcium / Vitamin D
Possible Cellcept side effects in male
Reported by a physician from Japan on 2012-06-15
Patient: male
Reactions: Colitis Ischaemic, Pneumonia, Abdominal Abscess, Cytomegalovirus Infection
Drug(s) suspected as cause:
Cellcept
Other drugs received by patient: Tacrolimus; Insulin; Basiliximab
Possible Cellcept side effects in 57 year old female
Reported by a physician from Japan on 2012-06-14
Patient: 57 year old female
Reactions: Acute Graft Versus Host Disease, Drug Ineffective, Pneumonia Bacterial, Cystitis Haemorrhagic, Cytomegalovirus Infection, Device Related Infection
Drug(s) suspected as cause:
Cellcept
Dosage: unk
Administration route: Oral
Indication: Prophylaxis Against Graft Versus Host Disease
Cellcept
Dosage: unk
Administration route: Oral
End date: 2010-12-01
Prograf
Dosage: unk
Administration route: Oral
End date: 2010-12-01
Prograf
Administration route: Oral
Indication: Prophylaxis Against Graft Versus Host Disease
Possible Cellcept side effects in 32 year old female
Reported by a physician from Taiwan, Province of China on 2012-06-13
Patient: 32 year old female
Reactions: Cytomegalovirus Infection, Transplant Rejection
Drug(s) suspected as cause:
Prednisolone
Start date: 2006-06-14
End date: 2006-06-17
Cellcept
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-12-20
End date: 2006-06-15
Cellcept
Start date: 2006-06-14
End date: 2006-06-17
Tacrolimus
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-12-20
End date: 2006-06-20
Rapamune
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-12-20
End date: 2006-06-17
Prednisolone
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-12-20
End date: 2006-06-14
Possible Cellcept side effects in male
Reported by a physician from Serbia on 2012-05-31
Patient: male, weighing 69.0 kg (151.8 pounds)
Reactions: Cardiopulmonary Failure, Otitis Media, Cytomegalovirus Infection, Gastric Ulcer
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Prednisolone
Indication: Renal Transplant
Start date: 2008-08-09
Tacrolimus
Administration route: Oral
Indication: Renal Transplant
Start date: 2008-08-14
Cellcept
Administration route: Oral
Indication: Renal Transplant
Start date: 2008-08-09
Other drugs received by patient: Ranisan; Ceftriaxone
Possible Cellcept side effects in female
Reported by a individual with unspecified qualification from Japan on 2012-05-10
Patient: female
Reactions: Post Transplant Lymphoproliferative Disorder, Gastric Cancer Stage 0, Anaemia, Cytomegalovirus Infection, Cerebellar Haemorrhage, Polyomavirus-Associated Nephropathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cellcept
Administration route: Oral
Start date: 2007-05-17
End date: 2007-06-17
Tacrolimus
Dosage: 2-14mg
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2007-05-02
Prednisolone
Dosage: 5-10mg
Administration route: Oral
Start date: 2007-05-04
Cellcept
Administration route: Oral
Start date: 2007-07-08
End date: 2008-02-01
Cellcept
Administration route: Oral
Muromonab-CD3
Dosage: dosage is uncertain.
Indication: Renal and Pancreas Transplant Rejection
Start date: 2007-12-01
End date: 2007-12-01
Tacrolimus
Cellcept
Administration route: Oral
Start date: 2007-06-18
End date: 2007-06-20
Prednisolone
Indication: Prophylaxis Against Transplant Rejection
Start date: 2007-04-27
End date: 2007-05-03
Cellcept
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2007-05-02
End date: 2007-05-10
Cellcept
Administration route: Oral
Start date: 2007-06-21
End date: 2007-06-22
Cellcept
Administration route: Oral
Start date: 2008-02-01
End date: 2008-10-01
Other drugs received by patient: Lantus; Novolin R; Insulin; Lansoprazole; Tacrolimus; Spanidin; Novorapid; Spanidin
Possible Cellcept side effects in 46 year old male
Reported by a physician from Japan on 2011-12-29
Patient: 46 year old male, weighing 52.0 kg (114.4 pounds)
Reactions: Pyrexia, Oropharyngeal Pain, Upper Respiratory Tract Inflammation, Hyperuricaemia, Oral Candidiasis, Nocardiosis, Serratia Test Positive, Asymptomatic Bacteriuria, Neurogenic Bladder, Urinary Tract Infection, Anaemia, Procedural Hypertension, Viral Upper Respiratory Tract Infection, Cytomegalovirus Chorioretinitis, Meningitis Cryptococcal, Cytomegalovirus Infection, Infection in AN Immunocompromised Host
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Prograf
Dosage: 3 mg, bid, oral
Administration route: Oral
Indication: Immunosuppressant Drug Therapy
Start date: 2006-07-18
Prednisolone
Dosage: 5;20 mg, unknown/d, oral
Administration route: Oral
Indication: Immunosuppressant Drug Therapy
Start date: 2006-07-15
Cellcept
Dosage: 500;250 mg, unknown d, oral
Administration route: Oral
Indication: Immunosuppressant Drug Therapy
Start date: 2006-07-12
Other drugs received by patient: Metoprolol Tartrate; Lansoprazole; Antifungals; Zantac; Diflucan; Basiliximab (Basiliximab); Amphotericin B; Ganciclovir; Fluconazole; Allopurinol; Amlodipine Besylate; Micardis; Ferromia (Ferrous Sodium Citrate); Urief (Silodosin); Avapro
|
